Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Dec 13 (Reuters)

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Dec 13, 2022 11:10am

71 Views

Post# 35168454

RE:RE:Dec 13 (Reuters)

Here's a foolish question; is the NASDAQ quoted price per share, or per ADR representing 25 shares?

prophetoffactz wrote: According to Stockhouse Midatech has 3.94 million shares and is on NASDAQ.

According to the poster's post it appears Midatech is the new BTI given the amount of shares being issued to BTI. BTI is now on NASDAQ:

"* MIDATECH PHARMA: DEAL TO BE SATISFIED BY ISSUE OF 75.9M NEW SHARES OF 0.1P EACH IN CO CAPITAL AT EXCHANGE RATIO OF 0.9556 SHARES FOR EACH BIOASIS SHARE Source text for Eikon: Further company coverage:"